Technical Analysis for JNJ - Johnson & Johnson

Grade Last Price % Change Price Change
D 152.67 0.85% 1.29
JNJ closed up 0.85 percent on Wednesday, May 15, 2024, on 74 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
Earnings due: May 29
*** please verify all earnings dates ***
24 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Flat Up

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Weak + Overbought Other 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.85%
Stochastic Reached Overbought Strength 0.85%
Weak + Overbought Other 0.85%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 18 hours ago
Rose Above 50 DMA about 18 hours ago
Up 1% about 18 hours ago
Rose Above Upper Bollinger Band about 18 hours ago
Rose Above Previous Day's High about 24 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Johnson & Johnson Description

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers products used in the baby care, skin care, oral care, wound care, and women's health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON'S, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VENDÔME, LISTERINE, REMBRANDT, REACH, BAND-AID, NEOSPORIN, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products directly, as well as through surgical supply and other distributors to wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: S&P 500 Immunology Pain Infectious Diseases Pharmaceutical Products Retail Outlets Infection Dow Jones Component Gastrointestinal Pharmacology Cardiovascular Disease Skin Care Urology Glucose Hematology Pain Management Insulin Wound Diagnostic Products Energy Products Neurology Blood Glucose Monitoring Lenses Contact Lens Infection Prevention Contact Lenses General Surgery Thrombosis Antipsychotic Infection Prevention Products Counter Pharmaceutical Products Insulin Delivery Johnson & Johnson Urological Products

Is JNJ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 171.9979
52 Week Low 142.7149
Average Volume 7,478,971
200-Day Moving Average 155.65
50-Day Moving Average 152.52
20-Day Moving Average 148.84
10-Day Moving Average 150.05
Average True Range 2.13
RSI (14) 58.68
ADX 18.31
+DI 25.93
-DI 16.15
Chandelier Exit (Long, 3 ATRs) 146.57
Chandelier Exit (Short, 3 ATRs) 149.51
Upper Bollinger Bands 152.86
Lower Bollinger Band 144.83
Percent B (%b) 0.98
BandWidth 5.39
MACD Line -0.07
MACD Signal Line -0.84
MACD Histogram 0.7728
Fundamentals Value
Market Cap 367.52 Billion
Num Shares 2.41 Billion
EPS 5.20
Price-to-Earnings (P/E) Ratio 29.36
Price-to-Sales 4.43
Price-to-Book 5.30
PEG Ratio 5.77
Dividend 4.70
Dividend Yield 3.08%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 155.15
Resistance 3 (R3) 154.96 153.96 154.73
Resistance 2 (R2) 153.96 153.33 154.05 154.59
Resistance 1 (R1) 153.31 152.94 153.64 153.50 154.46
Pivot Point 152.31 152.31 152.47 152.40 152.31
Support 1 (S1) 151.66 151.68 151.99 151.85 150.88
Support 2 (S2) 150.66 151.29 150.75 150.75
Support 3 (S3) 150.01 150.66 150.61
Support 4 (S4) 150.20